Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions (Q83948551)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

lymphoblastic leukemia

1 reference

Verheyden S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Demanet C

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

8 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1437-1438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16761016%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021

Identification of natural killer cell receptor phenotypes associated with leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021

Natural killer cell-triggering receptors in patients with acute leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404279

7 January 2021